Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

98 ARTÍCULOS , VIENDO DEL 1 AL 15

Epileptic seizures in AD patients

Larner AJ.

Neuromolecular Med. 2010 Mar;12(1):71-7. doi: 10.1007/s12017-009-8076-z. Epub 2009 Jun 26.

A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors

Jones RW.

Int J Geriatr Psychiatry. 2010 Jun;25(6):547-53. doi: 10.1002/gps.2384.

Role of vascular risk factors and vascular dysfunction in Alzheimer's disease

Dickstein DL, Walsh J, Brautigam H, Stockton SD Jr, Gandy S, Hof PR.

Mt Sinai J Med. 2010 Jan-Feb;77(1):82-102. doi: 10.1002/msj.20155.

Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study

Coduras A, Rabasa I, Frank A, Bermejo-Pareja F, López-Pousa S, López-Arrieta JM, Del Llano J, León T, Rejas J.

J Alzheimers Dis. 2010;19(2):601-15. doi: 10.3233/JAD-2010-1258.

Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables

Hernandez S, McClendon MJ, Zhou XH, Sachs M, Lerner AJ.

J Alzheimers Dis. 2010;19(2):665-72. doi: 10.3233/JAD-2010-1269.

Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment

Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, Inagaki H, Iwasa H, Ura C, Yatomi N, Ishii K, Tokumaru AM, Homma A, Nasreddine Z, Shinkai S.

Geriatr Gerontol Int. 2010 Jul;10(3):225-32. doi: 10.1111/j.1447-0594.2010.00585.x. Epub 2010 Feb 4.

A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression

Lladó A, Fortea J, Ojea T, Bosch B, Sanz P, Valls-Solé J, Clarimon J, Molinuevo JL, Sánchez-Valle R.

Eur J Neurol. 2010 Jul;17(7):994-6. doi: 10.1111/j.1468-1331.2010.02949.x. Epub 2010 Feb 10.

Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease

Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA.

Neurodegener Dis. 2010;7(1-3):38-41. doi: 10.1159/000283480. Epub 2010 Feb 13.

Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence

Szekely CA, Zandi PP.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):132-9. doi: 10.2174/187152710791012026.

[Do dementia patients living at home live longer than in a nursing home?]

Lankers D, Kissler S, Hötte SD, Freyberger HJ, Schröder SG.

Z Gerontol Geriatr. 2010 Aug;43(4):254-8. doi: 10.1007/s00391-010-0096-7. Epub 2010 Mar 18.

Current treatment options for people with Alzheimer's disease in Croatia

Mimica N, Presecki P.

Chem Biol Interact. 2010 Sep 6;187(1-3):409-10. doi: 10.1016/j.cbi.2010.03.029. Epub 2010 Mar 20.

Neuronutrition and Alzheimer's disease

Ramesh BN, Rao TS, Prakasam A, Sambamurti K, Rao KS.

J Alzheimers Dis. 2010;19(4):1123-39. doi: 10.3233/JAD-2010-1312.

Drugs for Alzheimer's disease

Cranwell-Bruce LA.

Medsurg Nurs. 2010 Jan-Feb;19(1):51-3.

Combination treatments in Alzheimer's disease: risks and benefits

Sobow T.

Expert Rev Neurother. 2010 May;10(5):693-702. doi: 10.1586/ern.10.43.

Reaching the limits of genome-wide significance in Alzheimer disease: back to the environment

Pedersen NL.

JAMA. 2010 May 12;303(18):1864-5. doi: 10.1001/jama.2010.609.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias